TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36333495

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (4000 IU/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (4000 IU/day) combined with exercise
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 35227308

Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment
Number of subjects: 4792

Group type: EXPERIMENTAL
Intervention: Delay in antimicrobials
Number of subjects: 4792

Group type: EXPERIMENTAL
Intervention: Time to surgical source control
Number of subjects: 4792

Group type: EXPERIMENTAL
Intervention: Delay of source control
Number of subjects: 4792
Study: 33301579

Group type: EXPERIMENTAL
Intervention: Treatment failure
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Elevated C-reactive protein level
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Length of stay (LOS)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Univariate analysis
Number of subjects: 140
Study: 35908682

Group type: EXPERIMENTAL
Intervention: Mechanical instrumentation with adjunct photodynamic therapy (PDT)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Mechanical instrumentation without adjunct photodynamic therapy (Control)
Number of subjects: 107
Study: 34802446

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) intervention
Number of subjects: 155

Group type: COMPARATOR
Intervention: Wait list control condition
Number of subjects: 155
Study: 33164955

Group type: EXPERIMENTAL
Intervention: Spiritual care training program
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 73
Study: 33387509

Group type: EXPERIMENTAL
Intervention: Durvalumab alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Durvalumab plus tremelimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 32035222

Group type: EXPERIMENTAL
Intervention: Endurance followed by resistance training (E + R; n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resistance followed by endurance training (R + E; n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (C; n = 10)
Number of subjects: 30
Study: 33559259

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Clobetasol propionate (0.05%)
Number of subjects: 11
Study: 32468174

Group type: EXPERIMENTAL
Intervention: Uphold™ hysteropexy (HP)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Vaginal hysterectomy (VH)
Number of subjects: 101
Study: 34461078

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (enoxaparin; 40 mg subcutaneously)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no low-molecular-weight heparin)
Number of subjects: 33
Study: 32049831

Group type: EXPERIMENTAL
Intervention: sugammadex 2 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: pyridostigmine 0.2 mg/kg plus glycopyrrolate 0.01 mg/kg
Number of subjects: 60
Study: 33980610

Group type: EXPERIMENTAL
Intervention: Pac-S-1 (paclitaxel + S-1)
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Pac-UFT (paclitaxel + UFT)
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Pac-Ram (paclitaxel + ramucirumab)
Number of subjects: 499
Study: 34534048

Group type: EXPERIMENTAL
Intervention: Fentanyl prior to colonoscopy
Number of subjects: 539

Group type: COMPARATOR
Intervention: Fentanyl on-demand
Number of subjects: 539

Group type: COMPARATOR
Intervention: Alfentanil on-demand
Number of subjects: 539
Study: 35271609

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: ICU admission
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Day 1, 3, and 5 measurements of copeptin and MR‐proADM
Number of subjects: 175
Study: 33296560

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated devices (drug-coated-device group)
Number of subjects: 2289

Group type: COMPARATOR
Intervention: Uncoated devices (uncoated-device group)
Number of subjects: 2289
Study: 34891224

Group type: EXPERIMENTAL
Intervention: Axicabtagene ciloleucel (axi-cel)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 359
Study: 33249735

Group type: EXPERIMENTAL
Intervention: 10% glucose
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 10% sucrose
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 10% sucrose + 60 ppm lactisole
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 10% glucose + 60 ppm lactisole
Number of subjects: 27
Study: 32102644

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 420

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 420
Study: 34313595

Group type: EXPERIMENTAL
Intervention: Engagement Facilitation Intervention (EFI) + myCompass 2
Number of subjects: 849

Group type: COMPARATOR
Intervention: myCompass 2 alone
Number of subjects: 849

Group type: COMPARATOR
Intervention: Attention control condition
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: myCompass 2
Number of subjects: 849
Study: 33648377

Group type: EXPERIMENTAL
Intervention: A0 pulley release
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: A1 pulley release
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both A0 and A1 pulley release
Number of subjects: 24

Group type: COMPARATOR
Intervention: Initial A1 release
Number of subjects: 24

Group type: COMPARATOR
Intervention: Initial A0 release
Number of subjects: 24
Study: 33559445

Group type: EXPERIMENTAL
Intervention: Fire needling stripping after local anesthesia
Number of subjects: 900

Group type: COMPARATOR
Intervention: Fire needling
Number of subjects: 900

Group type: COMPARATOR
Intervention: Liquid nitrogen cryotherapy
Number of subjects: 900
Study: 36261757

Group type: EXPERIMENTAL
Intervention: Potassium sodium hydrogen citrate (PSHC)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sodium bicarbonate (NaHCO3)
Number of subjects: 34
Study: 34469668

Group type: EXPERIMENTAL
Intervention: Bladder Training + Intravaginal Electrical Stimulation (BT+IVES)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Bladder Training (BT)
Number of subjects: 62
Study: 32720852

Group type: EXPERIMENTAL
Intervention: Double elastic band in the frontal plane
Number of subjects: 21

Group type: COMPARATOR
Intervention: Single elastic band in the frontal plane
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Double elastic band in the scapular plane
Number of subjects: 21
Study: 36442036

Group type: EXPERIMENTAL
Intervention: Active stimulation of the left DLPFC (n = 27)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Sham stimulation of the left DLPFC (n = 27)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Active stimulation of the right DLPFC (n = 25)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Sham stimulation of the right DLPFC (n = 24)
Number of subjects: 103
Study: 33938630

Group type: EXPERIMENTAL
Intervention: Orbera™ fluid‐filled intragastric balloon (IGB)
Number of subjects: 26
Study: 32812663

Group type: EXPERIMENTAL
Intervention: Cream containing niosomes loaded with 1% w/v purple glutinous rice extract
Number of subjects: 20
Study: 35675854

Group type: EXPERIMENTAL
Intervention: SBRT (24 Gy in 2 fractions)
Number of subjects: 137

Group type: COMPARATOR
Intervention: cEBRT (20 Gy in 5 fractions)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: SBRT
Number of subjects: 137

Group type: COMPARATOR
Intervention: cEBRT
Number of subjects: 137
Study: 34044454

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 2609

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2609
Study: 32702925

Group type: EXPERIMENTAL
Intervention: With drainage (WD group)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Without drainage (WOD group)
Number of subjects: 123
Study: 34027754

Group type: EXPERIMENTAL
Intervention: Video game-based training
Number of subjects: 66

Group type: COMPARATOR
Intervention: Motor-cognitive dual-task training
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 66
Study: 34166648

Group type: EXPERIMENTAL
Intervention: 52 mg levonorgestrel intrauterine system (IUS)
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: 380 mm(2) copper IUD
Number of subjects: 518
Study: 35579384

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 0
Study: 34175829

Group type: EXPERIMENTAL
Intervention: Pattern 3 C-peptide trajectory (undetectable at 12 and 24 weeks, detectable at 34 weeks)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Pattern 3 C-peptide trajectory
Number of subjects: 127

Group type: COMPARATOR
Intervention: Pattern 1 C-peptide trajectory (undetectable throughout pregnancy)
Number of subjects: 127
Study: 34251865

Group type: EXPERIMENTAL
Intervention: Technology-assisted case management intervention
Number of subjects: 113

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 113
Study: 33146332

Group type: EXPERIMENTAL
Intervention: BioRaCe system
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Reciproc system
Number of subjects: 47
Study: 35027169

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Oxygen (70 L min−1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Facemask Oxygen (15 L min−1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Oxygen
Number of subjects: 80
Study: 33609102

Group type: EXPERIMENTAL
Intervention: CuBlock normalization algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: ComBat, UPC, YuGene, DBNorm, Shambhala, simple log2 transform
Number of subjects: 0
Study: 32715556

Group type: EXPERIMENTAL
Intervention: Estradiol vaginal gel (25 μg, 2 mL applied intravaginally daily for 2 weeks, then two doses per week for 6 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (K‐Y® Jelly)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (Estradiol and Control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Estradiol vaginal gel and Control group
Number of subjects: 80
Study: 35503997

Group type: EXPERIMENTAL
Intervention: IV sodium ferric gluconate complex (SFGC) 125 mg per day for 3-5 days
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: IV sodium ferric gluconate complex (SFGC)
Number of subjects: 34
Study: 33977743

Group type: EXPERIMENTAL
Intervention: SHT intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Routine intervention (Control)
Number of subjects: 94
Study: 33499677

Group type: EXPERIMENTAL
Intervention: Gain frame
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Loss frame
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Certain outcome
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Uncertain outcome
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Frequency number format
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Percentage number format
Number of subjects: 413
Study: 33688840

Group type: EXPERIMENTAL
Intervention: Online mindfulness-based cognitive behavioral therapy (CBT-M) combined with standard psychiatric care (n=22)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard psychiatric care alone (n=23)
Number of subjects: 45
Study: 34736367

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 658

Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 658
Study: 34493219

Group type: EXPERIMENTAL
Intervention: Patient education booklet
Number of subjects: 0
Study: 32784162

Group type: EXPERIMENTAL
Intervention: Causse Loop Piston
Number of subjects: 148

Group type: COMPARATOR
Intervention: Big Easy Piston
Number of subjects: 148
Study: 35414614

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) group exposed to 3D natural videos with calm Quran or music voices via phone using VR glasses immediately after anesthesia until completion of skin suture
Number of subjects: 351

Group type: COMPARATOR
Intervention: Control group receiving routine hospital care
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) group
Number of subjects: 351
Study: 33782992

Group type: EXPERIMENTAL
Intervention: Flipped classroom
Number of subjects: 118

Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 118
Study: 32436277

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Resting state control condition
Number of subjects: 42
Study: 33944622

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX) at a starting dose of 0.5 mg/kg/day, titrated to 1.2 mg/kg/day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy controls (HCs) (n=80)
Number of subjects: 100
Study: 34331964

Group type: EXPERIMENTAL
Intervention: 24-h fasting
Number of subjects: 20

Group type: COMPARATOR
Intervention: 12-h fasting
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fasting (both 12-h and 24-h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fasting
Number of subjects: 20
Study: 33883841

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aerobic Exercise (AE)
Number of subjects: 30
Study: 34744060

Group type: EXPERIMENTAL
Intervention: Mg-Ca alloy scaffold
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Mg-Sr alloy scaffold
Number of subjects: 2
Study: 33795788

Group type: EXPERIMENTAL
Intervention: CYP2C19 genotyping
Number of subjects: 0
Study: 34158437

Group type: EXPERIMENTAL
Intervention: Scaling and Root Planing and Punica granatum chip
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scaling and Root Planing and Punica granatum gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaling and Root Planing alone
Number of subjects: 30
Study: 36817351

Group type: EXPERIMENTAL
Intervention: 600 mg ALA
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 35925030

Group type: EXPERIMENTAL
Intervention: Robot-assisted passive range of motion training combined with conventional rehabilitation
Number of subjects: 12
Study: 32040376

Group type: EXPERIMENTAL
Intervention: Healive
Number of subjects: 400

Group type: COMPARATOR
Intervention: Havrix
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Healive and Havrix
Number of subjects: 400
Study: 36096778

Group type: EXPERIMENTAL
Intervention: Elastic intramedullary nail (EIN)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Locking compression plate (LCP)
Number of subjects: 28
Study: 33565686

Group type: EXPERIMENTAL
Intervention: Sitagliptin 50 mg once daily
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 35177053

Group type: EXPERIMENTAL
Intervention: Dapagliflozin as an add-on therapy to standard of care (SoC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34087201

Group type: EXPERIMENTAL
Intervention: Automated pipeline for extracting polyp findings and assigning surveillance intervals
Number of subjects: 324

Group type: COMPARATOR
Intervention: Gastroenterologist determination of surveillance intervals
Number of subjects: 324
Study: 33961534

Group type: EXPERIMENTAL
Intervention: Red light LED therapy 2–3 times/week for 6 weeks
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Red light LED therapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (contralateral side)
Number of subjects: 8
Study: 34272142

Group type: EXPERIMENTAL
Intervention: Fast speaking rate
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Medium speaking rate
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Slow speaking rate
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Vocal loading tasks (VLTs)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Male participants
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 38
Study: 34875666

Group type: EXPERIMENTAL
Intervention: Stepped care for depression
Number of subjects: 260

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 260
Study: 33293656

Group type: EXPERIMENTAL
Intervention: Highly Active Antiretroviral Treatment (HAART)
Number of subjects: 800

Group type: COMPARATOR
Intervention: HAART naïve
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 800
Study: 35070202

Group type: EXPERIMENTAL
Intervention: Integrated exercise (IE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 33261620

Group type: EXPERIMENTAL
Intervention: Increasing training set size
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data augmentation (traditional and domain-specific)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient-specific Hounsfield unit windowing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model ensembles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of all beneficial strategies
Number of subjects: 0
Study: 36200477

Group type: EXPERIMENTAL
Intervention: Semaglutide 2.4 mg
Number of subjects: 2764

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2764
Study: 32646746

Group type: EXPERIMENTAL
Intervention: Downhill Running (DR)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Uphill Running (UR)
Number of subjects: 10
Study: 32946612

Group type: EXPERIMENTAL
Intervention: 0.06 μg of protein per dose of P pratense allergoid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.03 μg of protein per dose of P pratense allergoid
Number of subjects: 0
Study: 35085318

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided peripheral intravenous catheter (UL PIVC)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Standard long peripheral intravenous catheter (SL PIVC)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Vesicant doses (1 vs 0)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Vesicant doses (2 vs 0)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Vesicant doses (≥ 3 vs 0)
Number of subjects: 257
Study: 34746745

Group type: EXPERIMENTAL
Intervention: 45 mg of Depo-Provera
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 75 mg of Depo-Provera
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 105 mg of Depo-Provera
Number of subjects: 60

Group type: COMPARATOR
Intervention: Depo-subQ provera 104
Number of subjects: 60
Study: 32756843

Group type: EXPERIMENTAL
Intervention: 15 kg N da‐1
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 22.5 kg N da‐1
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: DMPP blended ammonium sulphate nitrate
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Urea with NBPT urease inhibitor
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Nitrogen treatments
Number of subjects: 3
Study: 33583462

Group type: EXPERIMENTAL
Intervention: Family Minds intervention
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 89
Study: 34142986

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation program (high level: CME score 32-35; low level: CME score 28-31) with ten sessions of 45 minutes each
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (no cognitive stimulation program)
Number of subjects: 201
Study: 32321880

Group type: EXPERIMENTAL
Intervention: Physiologically diffuse disease in the left anterior descending artery (LAD)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Physiologically focal disease in the left anterior descending artery (LAD)
Number of subjects: 671

Group type: COMPARATOR
Intervention: Non-LAD vessels
Number of subjects: 671
Study: 34928698

Group type: EXPERIMENTAL
Intervention: Bamlanivimab (7000 mg)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 32267235

Group type: EXPERIMENTAL
Intervention: Virtual reality team training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Live simulations team training
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (Virtual reality and Live simulations)
Number of subjects: 120
Study: 34547193

Group type: EXPERIMENTAL
Intervention: Mirabegron 25 mg daily
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 32518039

Group type: EXPERIMENTAL
Intervention: Manual fascial manipulation
Number of subjects: 19
Study: 36220847

Group type: EXPERIMENTAL
Intervention: Daily group: inhaled budesonide 1 mg once a day, reduced to 0.25 mg once a day after 12 weeks if well controlled, maintained until 52 weeks
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Intermittent high-dose group: inhaled budesonide 1 mg twice daily for 7 days during respiratory tract illness
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Intermittent medium-dose group: inhaled budesonide 0.5 mg twice daily until symptoms reduced or risk factors absent for 3 days
Number of subjects: 474

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 474
Study: 33533309

Group type: EXPERIMENTAL
Intervention: Higher narcissism levels
Number of subjects: 332
Study: 32930113

Group type: EXPERIMENTAL
Intervention: Kanglaite (KLT) injection combined with gefitinib
Number of subjects: 554

Group type: COMPARATOR
Intervention: Gefitinib alone
Number of subjects: 554
Study: 34767481

Group type: EXPERIMENTAL
Intervention: Behavioral nudges to clinicians prompting Serious Illness Conversations (SICs)
Number of subjects: 14607

Group type: COMPARATOR
Intervention: Control group (standard SICs without nudges)
Number of subjects: 14607
Study: 34684084

Group type: EXPERIMENTAL
Intervention: Colchicine for 30 days
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no colchicine)
Number of subjects: 56
Study: 35274859

Group type: EXPERIMENTAL
Intervention: BESTFertil for 3 months
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no BESTFertil)
Number of subjects: 63
Study: 33448007

Group type: EXPERIMENTAL
Intervention: Exercise group (EG, n = 34)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (CG, n = 32)
Number of subjects: 66
Study: 35513855

Group type: EXPERIMENTAL
Intervention: Individualised computerised cognitive training (MAKSCog) for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basic computerised cognitive training (active control)
Number of subjects: 0
Study: 33079329

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation (n=79)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Usual care (n=82)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 143